
Loading, please wait...

Loading, please wait...

The recently released National Health Accounts (NHA) 2022-23 estimates expose dramatic regional imbalances in Indian State Health Spending. While several northeastern states allocate substantial resources to healthcare, many wealthy states spend very little. In fact, many of India's richest states spend less than 1% of their Gross State Domestic Product (GSDP). Consequently, these spending gaps raise critical questions about public healthcare access and equitable infrastructure development across the country.
Specifically, Manipur led the country by spending 5.5% of its GSDP on health, up from 4.6% in 2021-22. Similarly, Meghalaya dedicated 4.4% of its economic output to healthcare, whereas Nagaland and Mizoram recorded 3.6% and 3.2% respectively. In contrast, several highly industrialized states failed to meet the 1% threshold. For instance, Karnataka's spending plummeted from 1.1% to 0.7% of its GSDP. Additionally, Maharashtra and Tamil Nadu saw their health allocations drop to 0.8% and 0.9% respectively. These declines occurred largely because the extraordinary, one-time pandemic expenditures of the previous year finally wound down.
Besides GSDP ratios, the report highlights major differences in per capita government healthcare expenditure. Puducherry recorded the highest per capita public health spending at Rs 10,675 among Union Territories with a legislature. Conversely, Uttar Pradesh reported one of the lowest per capita spends at Rs 1,419, followed closely by Jharkhand and Madhya Pradesh. Nevertheless, due to its massive population base, Uttar Pradesh registered the highest total public health expenditure at Rs 33,352 crore. This high total spending stands in stark contrast to its very low per capita delivery. Consequently, public healthcare experts emphasize that high aggregate spending does not automatically translate into adequate individual patient care.
This uneven financial distribution presents serious hurdles as states battle a rising burden of non-communicable diseases. Additionally, an aging demographic profile is steadily driving up clinical care costs. Therefore, the lack of robust public healthcare spending forces many families to depend on expensive private medical systems. To reverse this trend, state policymakers must prioritize systematic investment in primary and secondary healthcare infrastructure.
Q1: Why did healthcare spending decrease in some states in 2022-23 compared to the previous year?
Healthcare spending in 2021-22 was exceptionally high due to emergency COVID-19 vaccination drives and pandemic-related infrastructure expansion. Consequently, normal funding levels resumed in 2022-23.
Q2: Which state recorded the highest proportion of its GSDP spent on healthcare?
Manipur spent the highest proportion of its GSDP on healthcare, allocating 5.5% in 2022-23.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A detailed analysis of the National Health Accounts 2022-23 data, highlighting the healthcare spending disparities between smaller and larger Indian states....
4 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today